The Mobile Gamma Cameras Market is experiencing strong momentum driven by rising demand for point-of-care diagnostic imaging, advancements in nuclear...
A Tough Timepiece with a Purpose, Supporting Breast Cancer Research DOVER, N.J., Sept. 24, 2025 /PRNewswire/ -- Casio America, Inc. is excited to...
Time-lapse video of a thymeleaf speedwell reveals the reproductive strategy select plants may adopt when pollinators are scarce MELVILLE, N.Y., Sept....
The Sontag Innovation Fund and the Yuvaan Tiwari Foundation join Two Bear Capital to support FYR's growing oncology portfolio and...
SEOUL, South Korea and MONTREAL, Sept. 24, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics...
Catalio Capital Management leads successful raise to drive commercial expansion of upright product suite across particle and photon therapy. MIDDLETON,...
BCRF responds to scientific community's urgent need to sustain research NEW YORK, Sept. 24, 2025 /PRNewswire/ -- At a time...
NEW CASTLE, Del., Sept. 24, 2025 /PRNewswire/ -- IgniteData, the healthtech company behind Archer—an advanced EHR-to-EDC solution delivering fully automated, regulatory-grade...
Potential treatment for patients with breast cancer with metastasis to the brain with crofelemer would augment the significant responder analysis...
The Company will provide an update on its novel Doxorubicin containing Microneedle Array (D-MNA) treatment to non-invasively treat basal cell...
Data highlights ability of Akari’s ADC payload, PH1, to suppress the levels of the AR-V7 receptor that is responsible for...
Sapu003 Designed to Overcome Limitations of Afinitor®, FDA-Approved Oral Everolimus, by Delivering Full Strength of the Drug via Intravenous InjectionSAN...
Intends to Initiate Phase 1b Clinical Trial in TNBC at Mayo Clinic in Fourth Quarter 2025FLORHAM PARK, N.J. and LONDON...
THIO-101 Phase 2 trial to enroll patients in the U.S. as part of the expansion of the study in third-line...
SAN DIEGO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing...
Healthcare as the World’s Most Strategic Investment: KFSHRC CEO Calls for Global Collaboration at C3 Japan Summit H.E. Dr. Majid...
FG-3246 Phase 2 dose optimization trial to enroll 75 patients with metastatic castration-resistant prostate cancer (mCRPC) in the post-androgen receptor...
U.S. Fast Track designation underscores the strength of the alnodesertib clinical data generated to date and the high degree of...
Garching / Munich, Germany, and Breda, the Netherlands, September 24, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading...
TOKYO and GUANGZHOU, China, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Riken Genesis Co., Ltd. (Riken Genesis) and Burning Rock Biotech...